tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Smart Value
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Olema Pharmaceuticals (OLMA)
NASDAQ:OLMA
US Market
OLMA
Olema Pharmaceuticals
Overview
Analyst Forecasts
AI Stock Analysis
Financials
Dividends
Technical Analysis
Options
Chart
Earnings
Ownership
Historical Prices
Stock Buybacks
Similar Stocks
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports

Olema Pharmaceuticals (OLMA) Stock News & Sentiment

Compare
706 Followers
Positive Outlook on Olema Pharmaceuticals Driven by Promising Phase II Trial Results and Upcoming Phase III Initiation
Premium
Ratings
Positive Outlook on Olema Pharmaceuticals Driven by Promising Phase II Trial Results and Upcoming Phase III Initiation
4d ago
OLMA
Olema Oncology Reports 2024 Financial and Clinical Progress
Premium
Company Announcements
Olema Oncology Reports 2024 Financial and Clinical Progress
7d ago
OLMA
Promising Clinical Data and Market Opportunities Drive Buy Rating for Olema Pharmaceuticals
Premium
Ratings
Promising Clinical Data and Market Opportunities Drive Buy Rating for Olema Pharmaceuticals
9d ago
OLMA
Promising Efficacy of Olema Pharmaceuticals’ Palazestrant Supports Buy Rating
Premium
Ratings
Promising Efficacy of Olema Pharmaceuticals’ Palazestrant Supports Buy Rating
17d ago
OLMA
Olema Pharmaceuticals: Promising Clinical Results and Strong Financial Health Support Buy Rating
Premium
Ratings
Olema Pharmaceuticals: Promising Clinical Results and Strong Financial Health Support Buy Rating
21d ago
OLMA
Promising Efficacy of Olema Pharmaceuticals’ Breast Cancer Treatment Drives Buy Rating
Premium
Ratings
Promising Efficacy of Olema Pharmaceuticals’ Breast Cancer Treatment Drives Buy Rating
23d ago
OLMA
Olema Pharmaceuticals Unveils Strategic Priorities and Pipeline
Premium
Company Announcements
Olema Pharmaceuticals Unveils Strategic Priorities and Pipeline
23d ago
8K
OLMA
More OLMA News >

OLMA News on the Web

Olema Oncology Reports 2024 Financial and Clinical Progress
TipRanks News
Neutral
Oppenheimer Remains a Buy on Olema Pharmaceuticals (OLMA)
TipRanks News
Neutral
Olema Pharmaceuticals Inc Reports Q4 2024 EPS of -$0.63 and Net Loss of $33. ...
GuruFocus News
Bullish
Olema Pharmaceuticals (OLMA) Receives a Buy from Oppenheimer
TipRanks News
Neutral
Olema updated palazestrant combination trial, says Oppenheimer
The Fly
Neutral
Olema Pharmaceuticals Unveils Strategic Priorities and Pipeline
TipRanks News
Neutral
AstraZeneca data 'positive' for Olema's palazestrant, says H.C. Wainwright
The Fly
Neutral
Olema Oncology to Present at the TD Cowen 45th Annual Health Care Conference
Yahoo Finance
Neutral

News Score - Last 7 Days

Neutral
OLMA
Sector Average
Media Buzz
This Week3 articles
Weekly Average0 articles
News Sentiment
This Week59%
Sector Average62%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is OLMA’s Media Buzz Sentiment?
Currently, no data Available
What is OLMA’s weekly average amount of articles?
Currently, no data Available
What is OLMA’s News Sentiment?
59% of articles about OLMA were positive this week, compared to its sector average of 62%.
    Healthcare Stocks that are Trending in the News
    ALCAlcon
    SLNOSoleno Therapeutics
    BHCBausch Health Companies
    DYAIDyadic International
    ASMBAssembly Biosciences
    Showing the stocks with the most bullish news sentiment over the past week

    Become an Expert with TipRanks Premium

    What am I Missing?
    Make informed decisions based on Top Analysts' activity
    Know what industry insiders are buying
    Get actionable alerts from top Wall Street Analysts
    Find out before anyone else which stock is going to shoot up
    Get powerful stock screeners & detailed portfolio analysis
    Subscribe NowSee Plans & Pricing